Stay updated on Adjuvant Cisplatin, Radiation & Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the Adjuvant Cisplatin, Radiation & Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Adjuvant Cisplatin, Radiation & Pembrolizumab Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision history shows addition of v3.4.3 and deletion of v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-05T19:40:23.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is now shown, replacing v3.4.1; no study data or essential functionality appear to be affected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T01:49:10.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Internal site revision updated from v3.4.0 to v3.4.1 with no visible changes to study information or user interface. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T23:34:58.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Show glossary and QC-related metadata were added (Last Update Submitted that Met QC Criteria, No FEAR Act Data) and Revision: v3.4.0, while the prior labels (Last Update Submitted that met QC Criteria, No FEAR Act data) and Revision: v3.3.4 were removed.
    Difference
    0.2%
    Check dated 2026-01-28T21:16:52.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.3.4, replacing the prior Revision: v3.3.3. This is a minor maintenance update that does not alter the study content, endpoints, or user-facing functionality of the page.
    Difference
    0.1%
    Check dated 2026-01-14T03:48:24.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Added a Locations section listing Kentucky, Michigan, Ohio, South Carolina, and Texas. Removed the HHS Vulnerability Disclosure link and updated the page revision to v3.3.3.
    Difference
    0.7%
    Check dated 2025-12-23T21:04:23.000Z thumbnail image

Stay in the know with updates to Adjuvant Cisplatin, Radiation & Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Adjuvant Cisplatin, Radiation & Pembrolizumab Clinical Trial page.